Cargando…

A Pharmacovigilance Analysis of Daptomycin Use Based on CLSI Susceptible Dose-Dependent Category

INTRODUCTION: Daptomycin doses 8–12 mg/kg are recommended for susceptible dose-dependent Enterococcus species. However, data remain limited on safety outcomes of such dosing, compared to standard 4–6 mg/kg dosing. METHODS: In this retrospective cohort study, patients were stratified into daptomycin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ming M., Stevens, Ryan W., Adema, Jennifer L., Mara, Kristin C., Schuetz, Audrey N., Tande, Aaron J., Rivera, Christina G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581971/ https://www.ncbi.nlm.nih.gov/pubmed/37751018 http://dx.doi.org/10.1007/s40121-023-00868-0

Ejemplares similares

Understanding and Application of Daptomycin-Susceptible Dose-Dependent Category for Enterococcus: A Mixed-Methods Study
por: Adema, Jennifer L, et al.
Publicado: (2022)

CLSI announces availability of new CLSI microbiology documents
Publicado: (2007)

Susceptibility of Dermatophytes to Thiabendazole Using CLSI Broth Macrodilution
por: Robledo-Leal, Efrén, et al.
Publicado: (2012)

Targeting Dalbavancin Inoculum Effect: Adjunctive Single Dose of Daptomycin
por: Kebriaei, Razieh, et al.
Publicado: (2023)

Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?
por: Peghin, Maddalena, et al.
Publicado: (2019)

CLSI broth microdilution method for testing susceptibility of Malassezia pachydermatis to thiabendazole
por: Nascente, Patrícia da Silva, et al.
Publicado: (2009)

Comparison of clinical antibiotic susceptibility testing interpretations to CLSI standard interpretations
por: Hitchingham, Erin, et al.
Publicado: (2023)

Antifungal susceptibility profile of Trichosporon isolates: correlation between CLSI and etest methodologies
por: Lemes, Raquel M.L., et al.
Publicado: (2010)

Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance
por: Cusack, T.P., et al.
Publicado: (2019)

Ceftaroline Susceptibility among Isolates of MRSA: A Comparison of EUCAST and CLSI Breakpoints
por: Sachu, Arun
Publicado: (2023)

166. Evaluation of Daptomycin Prescribing Practices Based on Microbiologic Susceptibility Determination of “Susceptible-Dose Dependent” (SDD)
por: Rowley, Amy, et al.
Publicado: (2021)

Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital
por: Maraki, Sofia, et al.
Publicado: (2014)

Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus
por: Storm, Jeremy C, et al.
Publicado: (2012)

Molecular Identification and Antifungal Susceptibility Patterns of Clinical Dermatophytes Following CLSI and EUCAST Guidelines
por: Dabas, Yubhisha, et al.
Publicado: (2017)

Optimizing the Dosing Regimens of Daptomycin Based on the Susceptible Dose-Dependent Breakpoint against Vancomycin-Resistant Enterococci Infection
por: Santimaleeworagun, Wichai, et al.
Publicado: (2019)

Change of Antibiotic Susceptibility Testing Guidelines from CLSI to EUCAST: Influence on Cumulative Hospital Antibiograms
por: Wolfensberger, Aline, et al.
Publicado: (2013)

Emergence of a daptomycin-non-susceptible Enterococcus faecium strain that encodes mutations in DNA repair genes after high-dose daptomycin therapy
por: Matono, Takashi, et al.
Publicado: (2016)

1269. Differences in Interpretative Breakpoints Between CLSI, FDA and EUCAST Impact Reporting of Susceptibility and Resistance to Cefiderocol
por: Yamano, Yoshinori, et al.
Publicado: (2020)

Provisional Use of CLSI-Approved Quality Control Strains for Antimicrobial Susceptibility Testing of Mycoplasma (‘Mesomycoplasma’) hyorhinis
por: Käbisch, Lisa, et al.
Publicado: (2021)

Impact of CLSI Break Point Changes Over the Past Decade on Antimicrobial Susceptibility in Gram-Negative Bacteria
por: Johnson, Wesley, et al.
Publicado: (2021)

Daptomycin and vancomycin non-susceptible methicillin-resistant Staphylococcus aureus clonal lineages from bloodstream infection in a Brazilian teaching hospital
por: Damasco, Andreia Paredes, et al.
Publicado: (2019)

In Vitro Fluconazole and Voriconazole Susceptibilities of Candida Bloodstream Isolates in Korea: Use of the CLSI and EUCAST Epidemiological Cutoff Values
por: Jang, Min Joong, et al.
Publicado: (2013)

1599. Clinical Outcomes for Patients Treated with Fluoroquinolones for Bacteremia Caused by Enterobacteriaceae Reclassified as Not Susceptible by Updated CLSI Breakpoints
por: Fleischner, Zachary, et al.
Publicado: (2020)

Pharmacovigilance Bibliometrics: Visualizing Thematic Development in the Category of Pharmacology and Pharmacy in Web of Science
por: Wang, Li, et al.
Publicado: (2021)

Daptomycin susceptibility of methicillin resistant Staphylococcus aureus (MRSA)
por: Kaur, Rajneet, et al.
Publicado: (2012)

CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa
por: Karita, Etienne, et al.
Publicado: (2009)

Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin Activity
por: Steed, Molly E., et al.
Publicado: (2013)

Prevalence of susceptibility patterns of opportunistic bacteria in line with CLSI or EUCAST among Haemophilus parainfluenzae isolated from respiratory microbiota
por: Kosikowska, Urszula, et al.
Publicado: (2020)

2768. In Vitro Antibiotic Susceptibility Pattern of Non-diphtheriae Corynebacterium Isolates 2012-2023, reference lab experience
por: Saleh, Omar M Abu, et al.
Publicado: (2023)

596. Distinct, Segregated Daptomycin-Susceptible and Daptomycin-Nonsusceptible Staphylococcus aureus Populations Associated with Tricuspid-Valve Infective Endocarditis
por: Miller, Christopher R, et al.
Publicado: (2019)

Comparison of Clinical Laboratory Standards Institute (CLSI) Microdilution Method and VITEK 2 Automated Antifungal Susceptibility System for the Determination of Antifungal Susceptibility of Candida Species
por: Dalyan Cilo, Burcu, et al.
Publicado: (2021)

Interpretation of Antimicrobial Susceptibility Testing Using European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) Breakpoints: Analysis of Agreement
por: Gaur, Priyanka, et al.
Publicado: (2023)

Time to switch from CLSI to EUCAST? A Southeast Asian perspective
por: Cusack, T.P., et al.
Publicado: (2019)

Treatment of Staphylococcal Device Infections: Synergistic Daptomycin With Ceftaroline Versus Rifampin-Adjunct Therapy
por: Chang, Amy T, et al.
Publicado: (2020)

Association between daptomycin susceptibility and teicoplanin resistance in Staphylococcus epidermidis
por: Watanabe, Shinichi, et al.
Publicado: (2019)

Vancomycin or Daptomycin for Outpatient Parenteral Antibiotic Therapy: Does It Make a Difference in Patient Satisfaction?
por: Wu, Katherine H, et al.
Publicado: (2021)

High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: Case report
por: Chen, Liang-Yu, et al.
Publicado: (2011)

Comparative assessment of CDS, CLSI disc diffusion and Etest techniques for antimicrobial susceptibility testing of Neisseria gonorrhoeae: a 6-year study
por: Singh, Vikram, et al.
Publicado: (2012)

Comparison of M.I.C.E. and Etest with CLSI Agar Dilution for Antimicrobial Susceptibility Testing against Oxacillin-Resistant Staphylococcus spp
por: Campana, Eloiza H., et al.
Publicado: (2014)

In Vitro Azole and Amphotericin B Susceptibilities of Malassezia furfur from Bloodstream Infections Using E-Test and CLSI Broth Microdilution Methods
por: Rhimi, Wafa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_on1nqig2rjrbd0prbjfrekdc6v